Share:
Share this content in WeChat
X
Experience Exchanges
Application value of functional magnetic resonance in early diagnosing autoimmune encephalitis in and evaluating the prognosis in children
ZHANG Xiaomeng  SU Qin  LI Linlin  ZHUANG Mengli  CHAOLUMEN Qiqige 

Cite this article as: Zhang XM, Su Q, Li LL, et al. Application value of functional magnetic resonance in early diagnosing autoimmune encephalitis in and evaluating the prognosis in children[J]. Chin J Magn Reson Imaging, 2021, 12(11): 57-60, 65. DOI:10.12015/issn.1674-8034.2021.11.012.


[Abstract] Objective To explore the early diagnostic and prognostic value of functional magnetic resonance imaging (fMRI) in children with autoimmune encephalitis (AE).Materials and Methods: From January 2018 to May 2019, 50 children with AE and 80 children with viral encephalitis (VE) who were admitted to the Affiliated Hospital of Inner Mongolia Medical University Hospital were selected as the AE group and the VE group, respectively. MRI scans, diffusion weighted imaging (DWI), arterial spin label (ASL) perfusion imaging and 1H-magnetic resonance spectroscopy (1H-MRS) were performed respectively. The relative apparent diffusion coefficient (rADC) values of the lesion area, the normal area and the two relative ADC values were measured using DWI images, relative cerebral blood flow (rCBF) using ASL, and choline (Cho) near 2.01 ppm, N-Acetyl-L-aspartic acid (NAA) near 2.01 ppm, creatine (Cr) near 3.03 ppm and other markers and the areas under the peaks of CHo/NAA, Cho/Cr, and NAA/Cr using 1H-MRS image; the relative ratio of the area of the markers was calculated. The children with VE were grouped according to the different prognosis, and the SPSS 22.0 statistical software package was used for data analysis. ROC curve was established to analyze the diagnostic value of each functional parameter for VE and the predictive value of the prognosis of the children.Results The values of rADC and NAA/Cr in the AE group were higher than those in the VE group, and the values of relative regional cerebral blood flow (rrCBF) and Cho/Cr were lower than those in the VE group (t=17.979, 7.250, 4.982, 5.174, P<0.05). There was no significant difference in Cho/NAA between the two groups (P>0.05). The values of rADC and rCBFof children with poor prognosis VE were higher than those with good prognosis, and values of NAA/Cr were lower than those with good prognosis (t=2.835, 2.282, 2.162, P<0.05).Conclusions The rADC value in DWI, the rrCBF value in ASL, and the NAA/Cr value in 1H-MRS have a certain application value in the early differential diagnosis of AE and VE, and may reflect the prognosis of children with AE to a certain extent.
[Keywords] functional magnetic resonance imaging;autoimmune encephalitis;viral encephalitis;prognosis;diagnostic value

ZHANG Xiaomeng   SU Qin   LI Linlin   ZHUANG Mengli   CHAOLUMEN Qiqige*  

Department of Pediatrics, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010000, China

Chaolumen QQG, E-mail: chaolumenqi@126.com

Conflicts of interest   None.

ACKNOWLEDGMENTS "Science and Technology Millions Project" Project of Inner Mongolia Medical University (No. YKD2018KJBW-LH-019).
Received  2021-02-03
Accepted  2021-08-05
DOI: 10.12015/issn.1674-8034.2021.11.012
Cite this article as: Zhang XM, Su Q, Li LL, et al. Application value of functional magnetic resonance in early diagnosing autoimmune encephalitis in and evaluating the prognosis in children[J]. Chin J Magn Reson Imaging, 2021, 12(11): 57-60, 65. DOI:10.12015/issn.1674-8034.2021.11.012.

[1]
Graus F, Titulaer MJ, Balu R. A clinical approach to diagnosis of autoimmune encephalitis[J]. Lancet Neurol, 2016, 15(4): 391-404. DOI: 10.1016/S1474-4422(15)00401-9.
[2]
Yin Y, Jin K, Zhuang XM, et al. Imaging and clinical features of anti-N-methyl-D-aspartate receptor encephalitis in children[J]. Chin J Clin Imaging, 2019, 30(11): 769-772. DOI: 10.12117/jccmi.2019.11.003.
[3]
Mendel F. Autoimmune encephalitis in children[J]. J Child Neurol, 2018, 16(3): 192-201. DOI: 10.1055/s-0037-1604477.
[4]
Aydos U, Arhan E, Akdemir MZ, et al. Utility of brain fluorodeoxyglucose PET in children with possible autoimmune encephalitis[J]. Nucl Med Commun, 2020, 41(7): 154-159. DOI: 10.1097/MNM.0000000000001222.
[5]
Neurology branch of Chinese Medical Association. Expert consensus on diagnosis and treatment of autoimmune encephalitis in China[J]. Chin J Neurol, 2017, 50 (2): 91-98. DOI: 10.3760/cma.j.issn.1006-7876.2017.02.004.
[6]
Dale RC, Gorman MP, Lim M. Autoimmune encephalitis in children: clinical phenomenology, therapeutics, and emerging challenges[J]. Curr Opin Neurol, 2017, 30(3): 334-344. DOI: 10.1097/WCO.0000000000000443.
[7]
Wegener PA, Cleaveland R, Wendel EM, et al. Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies[J]. Neurol Neuroimmunol Neuroinflamm, 2020, 7(4): 731. DOI: 10.1212/NXI.0000000000000731.
[8]
Fu C, Xuan A, Gao YJ, et al. Imaging features of 18F-FDG PET/CT in patients with autoimmune encephalitis[J]. Chin J nucl med mol imaging, 2019, 39(3): 142-145. DOI: 10.3760/cma.j.issn.2095-2848.2019.03.004.
[9]
Christian G. The role of MRI in autoimmune encephalitis[J]. Zeitschrift Fur Epi, 2018, 31(2): 152-155. DOI: 10.1007/s10309-017-0159-5.
[10]
Dubey D, Pittock SJ, Kelly CR, et al.Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis[J]. Ann Neurol, 2018, 83(1): 166-177. DOI: 10.1002/ana.25131.
[11]
Lancaster E. The diagnosis and treatment of autoimmune encephalitis[J]. J Clin Neurol, 2016, 12(1): 1-13. DOI: 10.3988/jcn.2016.12.1.1.
[12]
Zhao ZY, Han WX, Li Q, et al. Clinical analysis of 10 patients with LGI-1 antibody associated autoimmune encephalitis[J]. J Clin Neurol, 2018, 31(6): 441-444. DOI: CNKI:SUN:LCSJ.0.2018-06-012.
[13]
Mooneyham GLC, Gallentine W, Mater HV. Evaluation and management of autoimmune encephalitis: a clinical overview for the practicing child psychiatrist.[J]. Child Adolesc Psychiatr Clin N Am, 2018, 27(1): 37-52. DOI: 10.1016/j.chc.2017.08.011.
[14]
Ren YJ, Yang YH, Zhai S, et al. MRI features and diagnosis of Rasmussen encephalitis in children[J]. J med imaging, 2019, 29(3): 350-353. DOI: CNKI:SUN:XYXZ.0.2019-03-002.
[15]
Alison WS, Benjamin G, Audrey K. The princess and the P-value: a case report of suspected autoimmune encephalitis and functional neurological disorder in a pediatric patient[J]. Appl Neuropsychol Child, 2020, 9(1): 13-20. . DOI: 10.1080/21622965.2018.1501373.
[16]
Mao S, song YJ. Clinical analysis of autoimmune encephalitis of six cases[J]. Tianjin Med, 2018, 7 (6): 337-341. DOI: CNKI:SUN:TJYZ.0.2018-04-010.
[17]
Barbagallo M, Vitaliti G, Pavone P, et al. Pediatric autoimmune encephalitis[J]. J Pediatr Neurosci, 2017, 12(2): 130-134. DOI: 10.4103/jpn.JPN_185_16.
[18]
Armangue T, Spatola M, Vlagea A, et al. Spanish herpes simplex encephalitis study group. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis[J]. Lancet Neurol, 2018, 17(9): 760-772. DOI: 10.1016/S1474-4422(18)30244-8.
[19]
Broadley J, Seneviratne U, Beech P, et al. Prognosticating autoimmune encephalitis: a systematic review[J]. J Autoimmun, 2019, 96(6): 24-34. DOI: 10.1016/j.jaut.2018.10.014.
[20]
Jeffrey K, Firas T, Eric S. Clinical presentation and outcome in autoimmune encephalitis associated with N-Type Voltage-Gated calcium channels in children[J]. J Child Neurol, 2019, 7(9): 499-505. DOI: 10.1177/0883073819840448.
[21]
Esposito S, Principi N, Calabresi P, et al. An evolving redefinition of autoimmune encephalitis[J]. Autoimmun Rev, 2019, 18(2): 155-163. DOI: 10.1016/j.autrev.2018.08.009.
[22]
Zhong YM, Zhu Y. EEG and MRI in prognostic assessment for children with viral encephalitis combined with convulsion[J]. Chin matern child health research, 2018, 29(1): 70-73. DOI: 10.3969/j.issn.1673-5293.2018.01.018.

PREV The clinical application value of constellation shuttling imaging technology based on T1W-3D sequence
NEXT MRI features identify combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma with arterial rim enhancement
  



Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn